Some of the more common side effects in clinical trials compared to placebo include: Gastrointestinal side effects such as nausea, vomiting, constipation, or diarrhea Abdominal pain Headache, dizziness Fatigue Dyspepsia, abdominal distension, eructation Hypoglycemia (low blood sugar) in patients with type 2 diabetes Flatulence, gastroenteritis, and gastroesophageal reflux disease (heartburn) Hypoglycemia (low blood sugar levels), a more serious side effect of GLP-1 drugs, may also occur
When combined with healthy eating and lifestyle changes, semaglutide and tirzepatide have helped many patients in West Jordan achieve steady, sustainable weight loss
For example, rates of nausea in incretin mimetic trials typically range from ~15% to 22% and discontinuation due to AEs range from ~3% to 8%
However, the specific duration can differ depending on: Individual health factors Dosage The bodys overall response to the treatment Effective Management of Semaglutide Side Effects Proper Semaglutide side effects management can significantly improve comfort and adherence to the treatment plan
Here are some of the findings: Of the 171 eyes with iAMD included in this study, 82 (48 percent) developed at least one large hyperTD during a median follow-up of 59.1 months
